Together we will beat cancer

Donate

ASCO 2021 news: follow-up treatments pave the way

One of the biggest meetings of the world’s cancer specialists took place this weekend. Usually located in Chicago, researchers and clinicians around the world met virtually this year to present the latest in cancer research at the American Society of Clinical Oncology (ASCO) annual meeting. Here’s a flavour of the some of the top research presented.

Read More

Potentially life-extending treatment for lung cancer available in England

A potentially life-extending treatment for some people with non small cell lung cancer (NSCLC) will now be available on the NHS in England.

Read More

Three new cancer drugs approved for NHS in Scotland

The three latest SMC decisions will provide new treatment options for some adults with non small cell lung cancer, multiple myeloma and a rare type of lymphoma.

Read More

Targeted drug for lung cancer approved for NHS use in England

The National Institute for Health and Care Excellence has approved the drug osimertinib to treat some adults in England with untreated, advanced lung cancer.

Read More

The power of philanthropy: TRACERx

In the first of a new blog series on the power of philanthropy, we look at TRACERx – the first longitudinal, large-scale study of lung cancer evolution.

Read More

Three new treatment options approved for NHS use in Scotland

The Scottish Medicines Consortium (SMC) has accepted 3 new cancer treatments for NHS use in Scotland

Read More

Targeted lung cancer treatment gets initial ‘no’ for NHS in England

Adults in England with advanced lung cancer will not have access to a new targeted cancer drug, lorlatinib (Lorviqua). 

Read More

Lung cancer immunotherapy combo added to Cancer Drugs Fund

Combining an immunotherapy with chemotherapy has been recommended as a treatment for some patients with lung cancer on the NHS in England.

Read More

Kidney and lung cancer drugs approved on the NHS in Scotland

One kidney cancer treatment and two lung cancer drugs have been recommended for use on the NHS in Scotland.

Read More

Lung cancer treatment combo given initial NHS ‘no’ in England

A treatment combination has been provisionally rejected for people with certain types of lung cancer on the NHS in England.

Read More